All Articles

An independent analysis shows a specialized OB/GYN staffing model improves maternal outcomes, lowers C-section rates, and delivers a significant return on investment.

Colonial Heights schools adopt AI gun detection to boost safety, but the tech faces scrutiny over its real-world effectiveness and privacy implications.

With 144% customer growth, Maestra's all-in-one AI platform is luring brands from established players, sparking a tech stack consolidation debate.

Shelly Irvine, a top IP damages expert, rejoins FTI Consulting, signaling a strategic push to dominate the complex world of global IP litigation.

US-vetted drones are heading north. EagleNXT's landmark sale to Canada signals a new era in security and a strategic shift away from Chinese tech.

Cyber threat intelligence firm Intel 471 elevates CINO Michael DeBolt to President, signaling a strategy to embed deep operational expertise into its core.

Two specialized firms are joining forces, creating BlackBirchSCR to offer a new, unified model for capital raising and strategic communications.

A new survey shows Canadians are cutting back on dating due to costs, with Gen Z leading the charge for financial transparency and frugal romance.

Catapult launches the portable Perch P2, a camera-based system using AI to track athlete performance anywhere, from the weight room to the field.

The strategic deal combines sensing systems with core materials, positioning Excelitas as a critical supplier for AI, semiconductor, and defense markets.

A landmark $1.5 billion financing deal for Aypa Power signals a new era for energy storage, accelerating the race to build a more resilient U.S. power grid.

A breakthrough in cancer therapy as Avacta's faridoxorubicin proves so safe, regulators have removed historic dosing limits tied to heart toxicity.

At DISTRIBUTECH 2026, Anterix unveiled a new brand, moving beyond spectrum to deliver integrated private wireless solutions for utility grid modernization.

Current blood thinners carry a risky trade-off. A new class of drugs targeting Factor XIa could prevent deadly clots without the dangerous bleeding.

In a crowded AI market, ActiveCampaign is betting on self-evaluation. Its acquisition of Feedback Intelligence aims to create AI that learns and improves.

PayPal replaces its CEO after just 16 months, bringing in HP's Enrique Lores to combat slowing growth and fierce competition in the digital payments race.

Industrial giant AMETEK acquires LKC Technologies, aiming to revolutionize eye care with portable diagnostic devices for early disease detection.

This Valentine's, the arcade giant is turning its viral Human Crane into a high-stakes proposal. But is winning a diamond ring as simple as 'play to win'?

Relay Therapeutics' experimental drug, zovegalisib, offers new hope for a common and hard-to-treat form of advanced breast cancer with a promising safety profile.

Novo Nordisk exec Karin Conde-Knape joins Valo as CSO, signaling a major validation for AI's role in creating next-generation medicines.